Literature DB >> 17437054

Obstructive suburethral mass after transurethral injection of dextranomer/hyaluronic acid copolymer.

Hassan A Abdelwahab1, Gamal M Ghoniem.   

Abstract

Dextranomer/hyaluronic acid copolymer (Zuidex(R)) is a new bulking agent. There is little data about the complications of using this substance as urethral bulking agent for the treatment of urinary stress incontinence. We are presenting a 59-year-old female patient who developed a suburethral mass and urinary retention after zuidex urethral injection. A stepwise approach for treatment was followed. Complete excision of the mass was the only curative procedure that succeeded.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437054     DOI: 10.1007/s00192-007-0368-y

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  8 in total

1.  Urethral diverticulum following transurethral collagen injection.

Authors:  J Q Clemens; W Bushman
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

2.  Periurethral pseudocyst following cystoscopic collagen injection.

Authors:  M A Wainstein; C G Klutke
Journal:  Urology       Date:  1998-05       Impact factor: 2.649

3.  Urethral prolapse after collagen injection.

Authors:  R L Harris; G W Cundiff; K W Coates; W A Addison; R C Bump
Journal:  Am J Obstet Gynecol       Date:  1998-03       Impact factor: 8.661

4.  Simple aspiration technique to address voiding dysfunction associated with transurethral injection of dextranomer/hyaluronic acid copolymer.

Authors:  Steven P Petrou; Raymond W Pak; Deborah J Lightner
Journal:  Urology       Date:  2006-06-13       Impact factor: 2.649

5.  Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.

Authors:  G Läckgren; N Wåhlin; E Sköldenberg; A Stenberg
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

6.  Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic Acid copolymer: preliminary results.

Authors:  Prem Puri; Boris Chertin; Murugesh Velayudham; Laxaman Dass; Eric Colhoun
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

7.  Complications of Teflon injection for stress urinary incontinence.

Authors:  P J Kiilholma; M B Chancellor; J Makinen; I H Hirsch; P J Klemi
Journal:  Neurourol Urodyn       Date:  1993       Impact factor: 2.696

8.  Suburethral abscess: a complication of periurethral collagen injection therapy.

Authors:  M T McLennan; A E Bent
Journal:  Obstet Gynecol       Date:  1998-10       Impact factor: 7.661

  8 in total
  5 in total

1.  Periurethral abscess following polyacrylamide hydrogel (Bulkamid) for stress urinary incontinence.

Authors:  D Gopinath; A R B Smith; F M Reid
Journal:  Int Urogynecol J       Date:  2012-04-18       Impact factor: 2.894

2.  Suburethral mass formation after injection of polydimethylsiloxane (Macroplastique®) urethral bulking agent.

Authors:  Erika J Wasenda; Charles W Nager
Journal:  Int Urogynecol J       Date:  2016-08-16       Impact factor: 2.894

3.  Advances in managing pelvic floor disorders.

Authors:  Joan Pitkin
Journal:  F1000 Med Rep       Date:  2009-11-16

Review 4.  Urethral bulking agents: techniques and outcomes.

Authors:  Ahmed F Kotb; Lysanne Campeau; Jacques Corcos
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

5.  Nonsurgical transurethral radiofrequency collagen denaturation: results at three years after treatment.

Authors:  Denise M Elser; Gretchen K Mitchell; John R Miklos; Kevin G Nickell; Kevin Cline; Harvey Winkler; W Glen Wells
Journal:  Adv Urol       Date:  2011-12-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.